Rigrodsky Law, P.A. is currently investigating Avid Bioservices, Inc. (NASDAQ: CDMO) for potential breaches of fiduciary duties and legal violations related to its acquisition by GHO Capital Partners LLP and Ampersand Capital Partners. Under the acquisition agreement, Avid shareholders are set to receive $12.50 per share in cash.
The law firm is examining whether the deal adequately protects shareholder interests and complies with legal standards. Shareholders who wish to learn more about their rights in this situation can visit Rigrodsky Law's website or contact the firm directly.
Rigrodsky Law, with offices in Delaware and New York, has a history of recovering substantial amounts for investors and implementing significant corporate governance reforms in cases of securities fraud and corporate class actions across the country.
For further inquiries, shareholders can reach out to attorneys Seth D. Rigrodsky or Gina M. Serra at the provided contact details. The firm emphasizes that past results do not guarantee similar outcomes in this case.
This investigation highlights the ongoing scrutiny of mergers and acquisitions in the healthcare sector, particularly regarding the protection of shareholder rights during buyouts.